{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:25:31Z","timestamp":1788884731474,"version":"build-2803163510"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is traditionally conceptualized as a disorder of insulin resistance and \u03b2-cell dysfunction driven by metabolic overload. Increasing evidence now implicates cellular senescence\u2014a stress-induced state of durable cell-cycle arrest accompanied by a pro-inflammatory senescence-associated secretory phenotype (SASP)\u2014as a biologically distinct contributor to metabolic dysfunction. Senolytic therapies, which selectively eliminate senescent cells by targeting senescent cell anti-apoptotic pathways (SCAPs), have therefore emerged as potential disease-modifying interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a structured narrative review of preclinical and human studies published between 2010 and 2025, identified through PubMed, Scopus, and Embase. Evidence was synthesized qualitatively, with emphasis on mechanistic plausibility, tissue specificity, translational readiness, and safety considerations relevant to T2DM and its complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Preclinical studies consistently demonstrate that clearance of senescent cells in adipose tissue, liver, and pancreatic islets improves insulin sensitivity, attenuates SASP-mediated inflammation, and preserves \u03b2-cell function across multiple diabetic models. Human evidence remains limited to small, short-duration pilot studies primarily designed to assess biological target engagement and short-term safety. These studies report reductions in senescence markers and inflammatory mediators following intermittent senolytic exposure, but lack standardized metabolic endpoints and long-term follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Senolytic therapy represents a biologically compelling yet still experimental strategy for addressing the intersection of metabolic dysfunction and biological aging in T2DM. By reframing T2DM as a disease of metabolic aging, this review positions cellular senescence as an upstream therapeutic target and provides a conceptual framework to guide future precision-based clinical trials, rather than advocating near-term clinical adoption. By integrating geroscience with diabetology, this review positions cellular senescence as a biologically upstream framework that may inform future precision-based and disease-modifying strategies in type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1799261","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:21:28Z","timestamp":1774243288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cellular senescence and metabolic aging in type 2 diabetes: mechanistic insights and translational implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Ammaar Riyaz","family":"Syed","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwan Abdulaziz","family":"Aloti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam Jehad","family":"Awad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim Iyad Ibrahim","family":"Alghoul","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ayman Mohamed Samy Aly","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Kharoufeh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Rangraze","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ras Al Khaimah (RAK) Medical and Health Science University","place":["Ras Al Khaimah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"B1","unstructured":"Diabetes: Fact sheet.\n          \n          2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B3","article-title":"IDF Diabetes Atlas 10th edition Scientific Committee","volume-title":"IDF Diabetes Atlas","author":"Magliano","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: Standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0416","article-title":"Regulation of cellular senescence in type 2 diabetes mellitus: From mechanisms to clinical applications","volume":"47","author":"Iwasaki","year":"2023","journal-title":"Diabetes Metab J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1276707","article-title":"The role of cellular senescence in metabolic diseases and the potential for senotherapeutic interventions","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14218\/ERHM.2025.00018","article-title":"The link between immune aging and type 2 diabetes: A review of mechanisms and implications","volume":"10","author":"Chakrabarti","year":"2025","journal-title":"Exploratory Res Hypothesis Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2023.02.021","article-title":"Cellular senescence in aging: Molecular basis, implications and therapeutic interventions","volume":"136","author":"Princilly","year":"2023","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jb\/article\/177\/3\/189\/7943490","article-title":"Functional diversity of senescent cells in driving ageing: A review","volume":"177","author":"Nakano","year":"2025","journal-title":"J Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: Defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.molmet.2022.101601","article-title":"Targeting cellular senescence in metabolic disease","volume":"66","author":"Palmer","year":"2022","journal-title":"Mol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cmet.2019.05.006","article-title":"Acceleration of \u03b2 cell aging determines diabetes and senolysis improves disease outcomes","volume":"30","author":"Aguayo-Mazzucato","year":"2019","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab058","article-title":"Senolytics: Potential for alleviating diabetes and its complications","volume":"162","author":"Palmer","year":"2021","journal-title":"Endocrinology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1212716","article-title":"Pancreatic \u03b2-cell senescence in diabetes: Mechanisms, markers and therapies","volume":"14","author":"Cha","year":"2023","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41514-024-00170-4","article-title":"Cell senescence in cardiometabolic diseases","volume":"10","author":"Grootaert","year":"2024","journal-title":"NPJ Aging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12979-024-00414-7","article-title":"The interplay between obesity, immunosenescence, and insulin resistance","volume":"21","author":"Shimi","year":"2024","journal-title":"Immun Ageing"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00663-7","article-title":"Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice","volume":"4","author":"Zumerle","year":"2024","journal-title":"Nat Aging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: From mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.803098","article-title":"Biliary epithelial senescence in liver disease: There will be SASP","volume":"8","author":"Meadows","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100581","DOI":"10.1016\/j.bj.2023.02.001","article-title":"Cellular senescence and the host immune system in aging and age-related disorders","volume":"46","author":"Giannoula","year":"2023","journal-title":"Biomed J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1196460","article-title":"Senescence: A double-edged sword in beta-cell health and failure","volume":"14","author":"Varghese","year":"2023","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1189015","article-title":"Cellular senescence: A double-edged sword in cancer therapy","volume":"13","author":"Xiao","year":"2023","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/dom.15329","article-title":"Metabolically healthy obese individuals are still at high risk for diabetes: Application of the marginal structural model","volume":"26","author":"Lee","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103062","article-title":"Meta-analysis investigating the role of interleukin-6 mediated inflammation in type 2 diabetes","volume":"61","author":"Bowker","year":"2020","journal-title":"EBioMedicine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1124353","article-title":"Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes","volume":"14","author":"Yu","year":"2023","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1128872","article-title":"RAGE signalling regulates the progression of diabetic complications","volume":"14","author":"Taguchi","year":"2023","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2023.02.007","article-title":"Organ-specific fuel rewiring in acute and chronic hypoxia redistributes glucose and fatty acid metabolism","volume":"35","author":"Midha","year":"2023","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1820","article-title":"Cellular senescence in type 2 diabetes: A therapeutic opportunity","volume":"64","author":"Palmer","year":"2015","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endocr\/bqab136","article-title":"Role of cellular senescence in type II diabetes","volume":"162","author":"Narasimhan","year":"2021","journal-title":"Endocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05307-0","article-title":"Senescence-associated \u03b2-galactosidase in subcutaneous adipose tissue associates with altered glycaemic status and truncal fat in severe obesity","volume":"64","author":"Rouault","year":"2021","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00620-x","article-title":"BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD\/NASH","volume":"4","author":"Baboota","year":"2022","journal-title":"Nat Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05535-x","article-title":"Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration","volume":"613","author":"Moiseeva","year":"2023","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00747-4","article-title":"Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog","volume":"5","author":"Magkouta","year":"2025","journal-title":"Nat Aging"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: The path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: From transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205581","article-title":"Exploring the effects of dasatinib, quercetin, and fisetin on DNA methylation clocks: A longitudinal study on senolytic interventions","volume":"16","author":"Lee","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111888","article-title":"Current senolytics: Mode of action, efficacy and limitations, and their future","volume":"217","author":"Nayeri Rad","year":"2024","journal-title":"Mech Ageing Dev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23237","DOI":"10.1038\/s41598-021-02544-0","article-title":"Senolytic effects of quercetin in an in-vitro model of pre-adipocytes and adipocytes induced senescence","volume":"11","author":"Zoico","year":"2021","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105612","article-title":"A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer\u2019s disease","volume":"113","author":"Millar","year":"2025","journal-title":"eBioMedicine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204483","article-title":"Clearance of p16^Ink4a-positive cells in a mouse transgenic model does not change \u03b2-cell mass and has limited effects on their proliferative capacity","volume":"15","author":"Bahour","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111995","article-title":"Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases","volume":"222","author":"Tavenier","year":"2024","journal-title":"Mech Ageing Dev"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.03.005","article-title":"Reducing senescent cell burden in aging and disease","volume":"26","author":"Pignolo","year":"2020","journal-title":"Trends Mol Med"},{"key":"B46","article-title":"Glucagon-like peptide-1 receptor agonists","volume-title":"StatPearls","author":"Collins","year":"2024"},{"key":"B47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.14336\/ad.2021.0928","article-title":"Novel insights into the roles and mechanisms of GLP-1 receptor agonists against aging-related diseases","volume":"13","author":"Peng","year":"2022","journal-title":"Aging Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/jci165933","article-title":"DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice","volume":"133","author":"Herman","year":"2023","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12950","article-title":"Targeting senescent cells alleviates obesity-induced metabolic dysfunction","volume":"18","author":"Palmer","year":"2019","journal-title":"Aging Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.869414","article-title":"Cellular senescence in diabetes mellitus: Distinct senotherapeutic strategies for adipose tissue and pancreatic \u03b2 cells","volume":"13","author":"Murakami","year":"2022","journal-title":"Front Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41467-022-29486-z","article-title":"Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice","volume":"13","author":"Vacurova","year":"2022","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12933-023-01955-9","article-title":"The tyrosine kinase inhibitor dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice","volume":"22","author":"Gu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7150\/thno.100991","article-title":"Clearance of senescent cells enhances skin wound healing in type 2 diabetic mice","volume":"14","author":"Samarawickrama","year":"2024","journal-title":"Theranostics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8507","article-title":"Fisetin clears senescent cells through the PI3K-AKT-BCL-2\/BCL-XL pathway to alleviate diabetic aortic aging","author":"Ji","year":"2025","journal-title":"Phytotherapy Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"EVIDoa2400009","DOI":"10.1056\/evidoa2400009","article-title":"Safety and efficacy of senolytic UBX1325 in diabetic macular edema","volume":"4","author":"Klier","year":"2025","journal-title":"NEJM Evidence"},{"key":"B56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1124\/molpharm.123.000803","article-title":"Pharmacological targeting of senescence with senolytics as a new therapeutic strategy for neurodegeneration","volume":"105","author":"Richardson","year":"2023","journal-title":"Mol Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c06898","article-title":"Supramolecular senolytics via intracellular oligomerization of peptides in response to elevated reactive oxygen species levels in aging cells","author":"Kim","year":"2023","journal-title":"J Am Chem Soc"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.01.002","article-title":"A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells","author":"Escriche-Navarro","year":"2024","journal-title":"Acta Biomaterialia"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-2969","article-title":"Abstract 2969: Targeting novel senescence markers by conditionally active biologics eliminates senescence-associated secretory phenotype in in vitro and in vivo models","author":"Wang","year":"2024","journal-title":"Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e2401085","DOI":"10.1002\/adhm.202401085","article-title":"Senolytic therapy enabled by senescent cell-sensitive biomimetic melanin nano-senolytics","volume":"13","author":"Zhang","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202400355","article-title":"Senolytic prodrugs: A promising approach to enhancing senescence-targeting intervention","author":"Chang","year":"2024","journal-title":"ChemBioChem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14437","article-title":"Senolytic treatment attenuates immune cell infiltration without improving IAV outcomes in aged mice","author":"Luna","year":"2025","journal-title":"Aging Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(21)00300-7","article-title":"The costs and benefits of senotherapeutics for human health","volume":"3","author":"Raffaele","year":"2022","journal-title":"Lancet Healthy Longevity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.896907","article-title":"Senolytics in the treatment of diabetic retinopathy","volume":"13","author":"Hassan","year":"2022","journal-title":"Front Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.06.025","article-title":"Antidiabetic effects of the senolytic agent dasatinib","volume":"96","author":"Salaami","year":"2021","journal-title":"Mayo Clinic Proc"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02802-4","article-title":"Therapeutic targeting of cellular senescence in diabetic macular edema: Preclinical and phase 1 trial results","volume":"30","author":"Crespo-Garcia","year":"2024","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/diabetology6060048","article-title":"Senolytic interventions for type 2 diabetes: Current evidence and future directions","volume":"6","author":"Sodini","year":"2025","journal-title":"Diabetology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1039\/C8FO01653D","article-title":"Fisetin supplementation prevents high-fat diet\u2013induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation","volume":"10","author":"Ge","year":"2019","journal-title":"Food Funct"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.783706","article-title":"Fisetin attenuates diabetic nephropathy-induced podocyte injury","volume":"13","author":"Dong","year":"2022","journal-title":"Front Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18124","article-title":"Fisetin treatment alleviates kidney injury in mice with diabetes and hyperuricemia","volume":"69","author":"Ren","year":"2023","journal-title":"J Cell Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01502-7","article-title":"The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events","volume":"23","author":"Sattari","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020244","article-title":"Cellular senescence in health, disease, and lens aging","volume":"18","author":"Qin","year":"2025","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1799261\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:21:31Z","timestamp":1774243291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1799261\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":72,"alternative-id":["10.3389\/fendo.2026.1799261"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1799261","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"1799261"}}